Respiratory syncytial virus is the second most common cause of infant mortality and a major
cause of morbidity and mortality in older adults (aged> 60 years). Efforts to develop a …

The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that
protect against severe disease and preferably drive herd immunity. Regulators in numerous …

Access to safe, effective, quality-assured antivenom products that are tailored to endemic
venomous snake species is a crucial component of recent coordinated efforts to reduce the …

Sound regulatory systems are critical for protecting public health against use of medical
products which do not meet international standards of quality, safety and efficacy. This …

The rapid global spread of infectious diseases, epitomized by the recent COVID-19
pandemic, has highlighted the critical need for effective cross-border pandemic …

The emergence of global health partnerships (GHPs) towards the end of the twentieth
century reflected concerns about slow progress in access to essential medicines, including …

Access to quality-assured medical products improves health and save lives. However, one
third of the world's population lacks timely access to quality-assured medicines while …

Importance Clinical research supporting US Food and Drug Administration (FDA) drug
approvals is largely conducted outside the US. Objective To characterize where drugs were …

Objective. To describe the current status of regulatory reliance in Latin America and the
Caribbean (LAC) by assessing the countries' regulatory frameworks to approve new …

The vision of the African Medicines Agency (AMA) is to ensure that all Africans have access
to affordable medical products that meet internationally recognized standards of quality …